World leaders made historic commitments to provide equal access to vaccines for all
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
On Jun. 4, 2020, world leaders pledged an additional US$ 8.8 billion for Gavi, the Vaccine Alliance, far…
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…
On Jun. 4, 2020, the U.S. Department of Health and Human Services (HHS) announced new Guidance that specified…
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India (SII) and Walvax pledged to…
On Jun. 4, 2020, data from the Broad Institute of MIT and Harvard, Massachusetts General Hospital, and the…
On Jun. 3, 2020, CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, announced a new…
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
On Jun. 2, 2020, Albert Einstein College of Medicine announced it had received a $1 million challenge grant…
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneï¾’s…
On Jun. 1, 2020, the Government of the Democratic Republic of the Congo announced that a new outbreak…
On Jun. 1, 2020, the USDA announced it is transitioning its virulent Newcastle disease (vND) efforts in southern…
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
On May 29, 2020, Moderna announced the first participants in each age cohort had been dosed in the…
On May 29, 2020, Johnson & Johnson announced that its Janssen Pharmaceutical subsidiary received a positive opinion from…
On May 28, 2020, the Jenner Institute, University of Oxford, UK and Advent Srl ï¾– an IRBM company,…
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
On May 26, 2020, Novavax announced enrollment of the first participants in a Phase 1/2 clinical trial of…
On May 26, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had awarded…
On May 22, 2020, data reports, published by the COVID-19 Genomics UK Consortium (COG-UK), showed the value in…
On May 21, 2020, Innovation Pharma announced that in vitro research independently conducted at a U.S. Regional Biocontainment…
On May 21, 2020, ADMA Biologics announced it had commenced the collection of convalescent plasma through its wholly-owned…
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossaï¾’s proprietary…
On May 19, 2020, the NIH has launched a multipronged study to understand the effects of the COVID-19…
On May 19, 2020, the FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to…